Trial Profile
Long-Term Safety Follow-Up of Patients Initiating Cladribine Tablets Therapy
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2011
Price :
$35
*
At a glance
- Drugs Cladribine (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms RECORD-MS
- Sponsors Merck Serono
- 07 Sep 2011 New trial record